Conventional measures underestimate glycaemia in cystic fibrosis patients

Diabetic Medicine

Volumn 21, Issue 7, 2004, Pages 691-696

  Dobson, L ^a   Sheldon, C D ^a   Hattersley, A T ^b  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Continuous glucose monitoring system; Cystic fibrosis; Cystic fibrosis related diabetes; Glycosylated haemoglobin; Oral glucose tolerance test

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BIOLOGICAL MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; MALE;

ADULT; CYSTIC FIBROSIS; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MONITORING, PHYSIOLOGIC; REPRODUCIBILITY OF RESULTS;

EID: 3142693578     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01219.x     Document Type: Article

References (36)

1. Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu S-C et al. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988; 112: 373-377.
2. Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992; 151: 684-687.
3. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000; 162: 891-895.
4. Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiotz PO, Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paed 1994; 83: 72-77.
5. Koch C, Lanng S. Diabetes Mellitus. In: Hodson ME, Geddes DM, eds. Cystic Fibrosis, 2nd edn. London: Arnold, 2000: 314-323.
6. World Health Organisation. Diagnosis and classification of diabetes mellitus. Geneva: WHO, 1999.
7. Yung B, Kemp M, Hooper J, Hodson M. Random blood glucose alone in the diagnosis of CFRD. Lancet 1997; 49: 619.
8. Yung B, Kemp M, Hooper J, Hodson M. The diagnosis of cystic fibrosis related diabetes: a selective approach in performing oral glucose tolerance test. Thorax 1999; 54: 40-43.
9. Moran A, Hardin DS, Rodman HM, Allen HF, Beall RJ, Borowitz D et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus. A consensus conference report. Diabetes Res Clin Prac 1999; 45: 61-73.
10. Dobson L, Hattersley AT, Tiley S, Elworthy S, Oades PJ, Sheldon CD. Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child 2002; 87: 430-431.
11. Mastrototaro J. The MiniMed Continuous Glucose Monitoring System (CGMS). J Paed Endocrin Metab 1999; 12: 751-758.
12. Dobson L, Sheldon CD, Hattersley AT. Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis. Diabetes Care 2003; 26: 1940-1941.
13. Roe JN, Smoller R. Bloodless glucose measurements. Crit Rev Therapeutic Drug Carrier Systems 1998; 15: 199-241.
14. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose. Diabetes Care 2001; 24: 1858-1862.
15. Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH et al. Performance evaluation of the MiniMed Continuous Glucose Monitoring System during home patient use. Diabetes Technol Ther 2000; 2: 49-56.
16. Gross TM, Mastrototaro JJ. Efficacy and reliability of the Continuous Glucose Monitoring System. Diabetes Technol Ther 2000; 2: S19-26.
17. Bantle JP, Thomas W. Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid. J Lab Clin Med 1997; 130: 436-441.
18. Aalders AL, Schmidt FJ, Schoonen AJM, Broek IR, Maessen AGFM, Doorenbos H. Development of a wearable glucose sensor; studies in healthy volunteers and in diabetic patients. Int J Art Organs 1991; 14: 102-8.
19. Lanng S, Hansen A, Thorsteinsson B, Nerup J, Koch C. Glucose tolerance with cystic fibrosis: five-year prospective study. Br Med J 1995; 311: 655-659.
20. De Schepper J, Dab I, Derde MP, Loeb H. Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated haemoglobin determinations. Eur J Pediatr 1991; 150: 403-406.
21. Solomon MP, Wilson DC, Corey M, Kalnins D, Zielenski J, Tsui LC et al. Glucose intolerance in children with cystic fibrosis. J Pediatr 2003; 142: 128-132.
22. 1c as a diagnostic test for cystic fibrosis related diabetes. In press.
23. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
24. Holl RW, Heinze E, Wolf A, Rank M, Teller WM. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis. Eur J Pediatr 1995; 152: 356-361.
25. Yung B, Noormohamed FH, Kemp M, Hooper J, Lant AF, Hodson ME. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta cell dysfunction. Diabetic Med 2002; 19: 221-226.
26. Lanng S, Thorsteinnson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr 1994; 83: 849-853.
27. Rolon MA, Benali K, Munck A, Navarro J, Clement A, Tubiana-Rufi N et al. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001; 90: 860-867.
28. Nousia-Arvanitakis S, Galli-Tsinopoulou A, Karamouzis M. Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. Acta Paediatr 2001; 90: 515-519.
29. Ferrannini E, Pilo A. Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance. J Clin Invest 1979; 64: 243.
30. Handwerger S, Roth J, Gorden P, Di Sant' Agnese P, Carpenter DF, Peter G. Glucose intolerance in cystic fibrosis. NEJM 1969; 281: 451-461.
31. Wilmshurst EG, Soeldner JS, Holsclaw DS, Kaufmann RL, Shwachman H, Aoki TT et al. Endogenous and exogenous insulin responses in patients with cystic fibrosis. Pediatrics 1975; 55: 75-82.
32. Lippe BM, Sperling MA, Dooley RR. Pancreatic alpha and beta cell functions in cystic fibrosis. Pediatrics 1977; 90: 751-755.
33. Cucinotta D, Conti Nibali S, Arrigo T, DiBenedetto A, Magazzu G, DiCesare E et al. Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance. Horm Res 1990; 34: 33-38.
34. Lanng S, Thorsteinsson B, Roder ME, Orskov C, Nerup J, Koch C. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in CF patients with diabetes. Acta Endocrin 1993; 128: 207-214.
35. Austin A, Kalhan SC, Orenstein D, Nixon P, Arslanian S. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endocrinol Metab 1994; 79: 80-85.
36. Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP. Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991; 118: 715-23.